Study in Children to Evaluate Non-Inferiority and Persistence up to 5 Years of GSK Bio Meningococcal Vaccine 134612

NCT00427908 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

613

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Meningococcal

Interventions

BIOLOGICAL: GSK Biolgicals' meningococcal vaccine 134612 (Nimenrix)
BIOLOGICAL: Mencevax™ ACWY
BIOLOGICAL: Meningitec™

Sponsor

GlaxoSmithKline